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Abstract
The prevalence of myocardial involvement in influenza infection ranges from 0% to 12%. The 2009 pH1N1
influenza virus, formerly known as swine flu, first appeared in Mexico and the United States of America in March
and April 2009 and has swept the globe with unprecedented speed. We report a case of fulminant myocarditis
associated with this virus treated successfully using extra-corporal membrane oxygenator.
Case report
An 18 year old previously fit and well female suffered
from lethargy and malaise for six weeks combined with
rigors, fever, nausea, vomiting and diarrhea over four
days. After collapsing on train, she was admitted to local
hospital where she was diagnosed of cardiogenic shock
with echocardiogram showing severely impaired left ven-
tricular function with ejection fraction of 20%. She was
started on Dobutamine and transferred to our institution
for further management. On arrival, the systolic blood
pressure was 54 mmHg, sinus tachycardia of 130 per
minute, tachypnea and the lactate of 13 mmol/l. The air
entry was good and there were no added sounds on aus-
cultation. She arrested shortly after arrival, was intubated
and ventilated and after 65 minutes of cardiopulmonary
resuscitation (CPR) a Veno - Arterial Extra corporal
membrane oxygenator (VA ECMO) was inserted. The
decision to put ECMO was based on need of short term
circulatory support and emergency situation. The option
of short term left ventricular assist device (LVAD) was
not feasible as patient was being resuscitated and could
not be moved in theatre for LVAD implantation. The left
femoral vessels accessed percutaneously by Seldinger
technique. A 17 and 21 French cannulae were inserted
into Femoral artery and vein respectively and connected
to ECMO circuit comprising Levitronic CentriMag pump
and Medtronic oxygenator. A 10 French cannula was
inserted in Femoral artery for distal limb perfusion and
connected to the main arterial cannula by ‘Y’ connection.
Cardiovascular stability could be achieved with initial
ECMO flow of 3 l/min and moderate doses of Noradre-
nalin and Adrenaline targeting a mean arterial pressure
of 60 mmHg. Due to the cardiogenic shock and the hypo-
tension caused by the low cardiac output state she devel-
oped acute kidney injury and was treated with
continuous veno-venous hemofiltration (CVVH). On day
3, she developed compartment syndrome in the leg on
the side of ECMO insertion which needed fasciotomy.
Viral PCR (Polymerase Chain Reaction) test detected
Influenza A RNA in nasal and throat secretions of the
patient confirming H1N1 Pandemic strain a week after
the admission and she was started on OD 5 mg Oselta-
mivir. After 10 days of mechanical support, left ventricu-
lar function improved significantly and ejection fraction
of 50-55% with the ECMO flows turned down to mini-
mal. The ECMO was weaned off but the ischemic left leg
continued to deteriorate despite fasciotomy and revision
surgery and left above knee amputation had to be per-
formed. Patient was found intact neurologically from the
4
th day of ECMO insertion but kept sedated electively till
ECMO was out. Weaning from ventilator and CVVH was
unremarkable. Follow up investigations with MRI showed
an EF 72%, normal volume and thickness of the ventricle
and no regional wall motion abnormalities.
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T h ep r e v a l e n c eo fm y o c a r d i a l involvement in influenza
infection ranges from 0% to 12% [1]. Moreover, 2009
pH1N1 influenza virus (formerly known as swine flu)
first appeared in Mexico and the United States in
March and April 2009 and has swept the globe with
unprecedented speed [2]. Acute myocarditis during
influenza infection is a well-known complication, and
the clinical expression varies from asymptomatic to fatal
congestive cardiac failure and sometimes death [3]. Ful-
minant myocarditis (FM) is characterized clinically by
distinct onset of cardiac symptoms in otherwise young
healthy patients after nonspecific flu-like symptoms
rapidly resulting in severe ventricular dysfunction and
cardiogenic shock. Mortality up to 30% is reported in
FM [4]. Influenza-associated fulminant myocarditis in
adults is exceedingly rare [5]. Chacko et al in their
experience with 2009 pandemic of H1N1 virus reports
high incidence of myocardial injury and dysfunction and
was associated with high mortality [6]. Few cases of FM
secondary to H1N1 influenza infection are reported in
the literature [7-10].
Use of mechanical ventricular support device in FM
with severe ventricular failure is well established [7,8].
But, the choice of the device is still debated. In the
acute forms of myocarditis expected to be on circulatory
support for a long time, may be as a bridge to trans-
plant, the implantable LVAD is more appropriate. How-
ever, FM is expected to recover in short time and the
device is indicated as a bridge-to-recovery. So, an extra-
corporal device seems logical [8]. In the present case,
the patient was arrested and being resuscitated. In such
emergent situations it is difficult to move the patient to
theatre and open chest for short term LVAD implanta-
tion. Peripheral ECMO insertion is easy, can be done
with on-going CPR and at the bed side.
A hospital in New York reports use of a catheter-
based mechanical cardiac assist device (Impella 2.5 Car-
diac Assist Device, Abiomed, Danvers, MA) in a patient
of fulminant myocarditis secondary to H1N1 influenza,
but patient could not survive [9]. Komai et al reports
unsuccessful use of mechanical circulatory support in
FM [10]. However, some recent reports comment about
successful outcome in FM following H1N1 infection
with the use of mechanical circulatory support in the
form of ECMO [11,12]. In the present case, we sup-
ported the failing heart in FM due to H1N1 Influenza
infection with VA ECMO for 10 days leading to com-
plete recovery. This is the first case of H1N1 related FM
in Europe treated successfully with mechanical circula-
tory support. The myocardial biopsy to prove the origin
of myocarditis was not done in view of dilated thinned
out ventricular walls; however, typical symptoms and
positive viral PCR test for H1N1 were of abundant
evidence.
A subset of pH1N1 patients with FM can deteriorate
fast. They should be treated in Intensive Therapy Units
and monitored carefully for the declining heart function.
If not responding to maximum inotropic support, the
option of mechanical circulatory support should not be
delayed. Peripherally inserted veno-arterial ECMO is
efficient short term circulatory support which can be
weaned off with recovery of heart function or can be
converted to LVAD if respiratory function is optimum
and heart do not recover after 3-4 weeks.
Conclusion
H1N1 Influenza infection can cause Fulminant Myocar-
ditis leading to rapidly progressing heart failure which
can be fatal if not treated in time. Early intervention
with extra-corporal life support is indicated in fulminant
myocarditis associated with H1N1 influenza infection.
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